The effects of drotrecogin alfa (activated) on hospital mortality, length of stay and discharge location
Laterre PF, Levy H, Balk D, et al. The effects of drotrecogin alfa (activated) on hospital mortality, length of stay and discharge location. Chest. 2002;122:51S.
This article describes the effects of drotrecogin alfa on various treatment outcome criteria.
|
This item has not yet been rated
|
 |
Visit this journal's website
|
